Page last updated: 2024-08-21

adamantane and Lymphoma, T-Cell

adamantane has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amirkhosravi, A; Arlt, MJ; Banke, IJ; Krüger, A; Moroder, L; Mueller, MM; Sperl, S; Stemberger, A; Stürzebecher, J	1

Other Studies

1 other study(ies) available for adamantane and Lymphoma, T-Cell

Article	Year
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity. Thrombosis and haemostasis, 2005, Volume: 94, Issue:5 Topics: Adamantane; Animals; Anticoagulants; Antineoplastic Agents; Factor Xa; Factor Xa Inhibitors; Female; Fibrosarcoma; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, T-Cell; Mice; Mice, Inbred DBA; Naphthalenes; Propionates; Serine Proteinase Inhibitors; Specific Pathogen-Free Organisms; Whole Blood Coagulation Time	2005

Article

Year

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity.

Thrombosis and haemostasis, 2005, Volume: 94, Issue:5

Topics: Adamantane; Animals; Anticoagulants; Antineoplastic Agents; Factor Xa; Factor Xa Inhibitors; Female; Fibrosarcoma; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, T-Cell; Mice; Mice, Inbred DBA; Naphthalenes; Propionates; Serine Proteinase Inhibitors; Specific Pathogen-Free Organisms; Whole Blood Coagulation Time

2005